Associate Professor to Professor - Human Translational Infectious Disease and Immunology
Listed on 2026-11-06
-
Research/Development
Infectious Disease/ Epidemiology, Immunology Research
The Vaccine & Gene Therapy Institute (VGTI) at Oregon Health & Science University (OHSU) invites applications for a faculty position at the rank of Associate Professor or Professor
. Academic rank, faculty track, tenure status, departmental appointment, and compensation will be commensurate with the successful candidate’s qualifications and experience and determined in accordance with OHSU policy.
VGTI seeks an accomplished, collaborative scientist whose research is centered on human translational infectious disease or immunology
. The successful candidate will lead an innovative, externally funded research program that uses human populations, clinical cohorts, biospecimens, or patient-linked data to define mechanisms of infection and immunity and accelerate the development or evaluation of vaccines, therapeutics, diagnostics, biomarkers, or curative strategies. The VGTI is particularly interested in investigators who can create durable connections among human disease, mechanistic discovery, experimental models, and clinical translation.
Relevant areas include, but are not limited to:
- Human immune responses to acute, chronic, latent, emerging, or re-emerging infections
- Vaccine immunology, immune correlates of protection, antigen discovery, and immune monitoring
- Pathogen persistence, latency, reservoirs, immune evasion, and mechanisms of treatment response or failure
- Immunity across the lifespan, including pediatric immunity, immune aging, and infection in immunocompromised populations
- Translational systems immunology; single-cell, spatial, genomic, transcriptomic, proteomic, or computational approaches
- Biomarker, diagnostic, therapeutic, or vaccine development using human cohorts and biospecimens
- Clinical and translational research addressing HIV, herpes viruses, tuberculosis, malaria, emerging viruses, or other infectious diseases that complement and extend VGTI strengths
VGTI brings together multidisciplinary investigators to address serious infectious disease threats and to move discoveries from molecular and cellular studies through animal models and ultimately into clinical testing. Current strengths include HIV/AIDS, herpes virus biology, tuberculosis, malaria, emerging viruses with pandemic potential, viral pathogenesis, vaccine development, host–pathogen interactions, and the immunology of aging.
Located on OHSU’s West Campus adjacent to ONPRC, VGTI provides access to biosafety level 3 laboratories and advanced technologies that include spatial profiling, single-cell transcriptomics, flow cytometry, genomics, virology, advanced imaging, quantitative PCR, and proteomics. OHSU’s clinical programs and statewide partnerships create significant opportunities to expand human-focused investigation. The Division of Infectious Diseases, Pediatrics and Internal Medicine links clinical care and translational research across HIV, mycobacterial disease, infections in immunocompromised hosts, viral immunology, antimicrobial resistance, fungal and parasitic infections, and related fields, while the Oregon Clinical and Translational Research Institute (OCTRI) supports recruitment, biospecimen access, study coordination, and community engagement.
OHSU is Oregon’s only public academic health center and integrates research, education, clinical care, and statewide service. Its mission explicitly emphasizes interdisciplinary inquiry and translation of basic, clinical, and applied discoveries into health applications.
The successful candidate will:
- Establish, maintain, and grow an independent, nationally or internationally recognized research program in human translational infectious disease or immunology
- Sustain a strong portfolio of peer-reviewed extramural funding and pursue collaborative, multi-investigator,…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).